RNF144A and breast carcinoma: To determine whether aberrant promoter hypermethylation underlines altered RNF144A expression in breast cancer, we next analyzed the presence of any putative CpG islands on its promoter (−1000 to +100 relative to the transcription start site) using the MethPrimer program 24.